188 related articles for article (PubMed ID: 31604453)
21. Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.
Bhat A; Shah R; Bhat GR; Verma S; Sharma V; Sharma I; Pandita M; Bakshi D; Sharma B; Suri J; Kumar R
Genet Test Mol Biomarkers; 2019 Mar; 23(3):176-179. PubMed ID: 30810385
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
[TBL] [Abstract][Full Text] [Related]
23. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
25. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
26. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
27. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
28. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.
Lautner-Csorba O; Gézsi A; Semsei AF; Antal P; Erdélyi DJ; Schermann G; Kutszegi N; Csordás K; Hegyi M; Kovács G; Falus A; Szalai C
BMC Med Genomics; 2012 Sep; 5():42. PubMed ID: 23021489
[TBL] [Abstract][Full Text] [Related]
29. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
[TBL] [Abstract][Full Text] [Related]
30. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
31. A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children.
de Smith AJ; Wahlster L; Jeon S; Kachuri L; Black S; Langie J; Cato LD; Nakatsuka N; Chan TF; Xia G; Mazumder S; Yang W; Gazal S; Eng C; Hu D; Burchard EG; Ziv E; Metayer C; Mancuso N; Yang JJ; Ma X; Wiemels JL; Yu F; Chiang CWK; Sankaran VG
Cell Genom; 2024 Apr; 4(4):100526. PubMed ID: 38537633
[TBL] [Abstract][Full Text] [Related]
32. Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.
Lana T; de Lorenzo P; Bresolin S; Bronzini I; den Boer ML; Cavé H; Froňková E; Stanulla M; Zaliova M; Harrison CJ; de Groot H; Valsecchi MG; Biondi A; Basso G; Cazzaniga G; te Kronnie G
Leukemia; 2015 Oct; 29(10):2107-10. PubMed ID: 25778098
[No Abstract] [Full Text] [Related]
33. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
[TBL] [Abstract][Full Text] [Related]
34. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.
Bielska M; Borowiec M; Jesionek-Kupnicka D; Braun M; Bojo M; Pastorczak A; Kalinka-Warzocha E; Prochorec-Sobieszek M; Robak T; Warzocha K; Młynarski W; Lech-Marańda E
Int J Hematol; 2017 Dec; 106(6):794-800. PubMed ID: 28879630
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
[No Abstract] [Full Text] [Related]
36. IKZF1 polymorphisms are associated with susceptibility, cytokine levels, and clinical features in systemic lupus erythematosus.
Chen L; Niu Q; Huang Z; Yang B; Wu Y; Zhang J
Medicine (Baltimore); 2020 Oct; 99(41):e22607. PubMed ID: 33031316
[TBL] [Abstract][Full Text] [Related]
37. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
[No Abstract] [Full Text] [Related]
38. Loss-of-function but not dominant-negative intragenic
Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
[TBL] [Abstract][Full Text] [Related]
39. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
40. IKZF1 Gene Deletion in Pediatric Patients Diagnosed with Acute Lymphoblastic Leukemia in Mexico.
Ayón-Pérez MF; Pimentel-Gutiérrez HJ; Durán-Avelar MJ; Vibanco-Pérez N; Pérez-Peraza VM; Pérez-González ÓA; Barrientos-Ríos R; Santillán-Ávila CF; Zambrano-Zaragoza JF; Agraz-Cibrián JM; Gutiérrez-Franco J; Vázquez-Reyes A
Cytogenet Genome Res; 2019; 158(1):10-16. PubMed ID: 30974435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]